Información de Intuitive Surgical Inc, dividendo de Intuitive Surgical Inc, actividades de los accionistas y más

Información de Intuitive Surgical Inc Compañía

Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.

Información de la empresa

Código de la empresaISRG

Nombre de la empresaIntuitive Surgical Inc

Fecha de salida a bolsaJun 13, 2000

Fundada en1995

Director ejecutivoDr. Gary S. Guthart, Ph.D.

Número de empleados15638

Tipo de títulosOrdinary Share

Fin del año fiscalJun 13

Dirección1020 Kifer Road

CiudadSUNNYVALE

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal94086

Teléfono14085232100

Sitio Webhttps://www.intuitive.com/en-us/about-us/company

Código de la empresaISRG

Fecha de salida a bolsaJun 13, 2000

Fundada en1995

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionados

Cambio

Dr. Gary S. Guthart, Ph.D.

Chief Executive Officer, Director

1.27M

+1.05%

Mr. David J. Rosa

President, Director

231.87K

+5.81%

Dr. Craig H. Barratt, Ph.D.

Independent Chairman of the Board

26.16K

+3.17%

Ms. Amal M. Johnson

Independent Director

12.28K

--

Mr. Henry L. Charlton

Executive Vice President, Chief Commercial and Marketing Officer

7.73K

+157.65%

Mr. Joseph C. Beery

Independent Director

2.37K

--

Mr. Mark Preston Brosius

Senior Vice President, Chief Manufacturing and Supply Chain Officer

2.04K

-54.69%

Dr. Monica P. Reed, M.D.

Independent Director

1.61K

--

Dr. Amy L. Ladd, M.D.

Independent Director

671.00

-18.27%

Ms. Sreelakshmi Kolli

Independent Director

240.00

--

Nombre

Nombre/Posición

Posición

Accionados

Cambio

Dr. Gary S. Guthart, Ph.D.

Chief Executive Officer, Director

1.27M

+1.05%

Mr. David J. Rosa

President, Director

231.87K

+5.81%

Dr. Craig H. Barratt, Ph.D.

Independent Chairman of the Board

26.16K

+3.17%

Ms. Amal M. Johnson

Independent Director

12.28K

--

Mr. Henry L. Charlton

Executive Vice President, Chief Commercial and Marketing Officer

7.73K

+157.65%

Mr. Joseph C. Beery

Independent Director

2.37K

--

Desglose de ingresos

Divisa: USDHora de actualización: mié., 2 de abr

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

FY2018

Por negocioUSD

Nombre

Ganancia

Proporción

Instruments and accessories

5.08B

60.81%

Systems

1.97B

23.54%

Services

1.31B

15.65%

Por regiónUSD

Nombre

Ganancia

Proporción

U.S.

5.59B

66.92%

Outside of United states

2.76B

33.08%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Instruments and accessories

5.08B

60.81%

Systems

1.97B

23.54%

Services

1.31B

15.65%

Accionista

Hora de actualización: vie., 21 de feb

Estadísticas de accionistas

Tipo

Estadísticas de accionistas

Accionista

Proporción

The Vanguard Group, Inc.

8.95%

BlackRock Institutional Trust Company, N.A.

5.18%

State Street Global Advisors (US)

4.27%

T. Rowe Price Associates, Inc.

3.90%

Fidelity Management & Research Company LLC

2.93%

Other

74.77%

Estadísticas de accionistas

Accionista

Proporción

The Vanguard Group, Inc.

8.95%

BlackRock Institutional Trust Company, N.A.

5.18%

State Street Global Advisors (US)

4.27%

T. Rowe Price Associates, Inc.

3.90%

Fidelity Management & Research Company LLC

2.93%

Other

74.77%

Tipo

Accionista

Proporción

Investment Advisor

43.07%

Investment Advisor/Hedge Fund

35.61%

Bank and Trust

2.46%

Research Firm

2.40%

Pension Fund

2.20%

Hedge Fund

1.76%

Sovereign Wealth Fund

1.39%

Individual Investor

0.50%

Foundation

0.15%

Other

10.46%

Participación institucional

Hora de actualización: dom., 19 de ene

Periodo de informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q1

3377

322.64M

90.05%

-654.22K

2024Q4

3426

322.11M

90.31%

-1.17M

2024Q3

3255

319.27M

89.84%

-8.25M

2024Q2

3152

322.86M

91.02%

+572.17K

2024Q1

3116

317.58M

89.60%

-829.16K

2023Q4

3055

314.33M

89.27%

-2.70M

2023Q3

2961

312.82M

89.02%

-3.61M

2023Q2

2932

311.78M

88.97%

-2.17M

2023Q1

2848

309.16M

88.25%

-6.75M

2022Q4

2840

310.11M

87.74%

-7.77M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

32.06M

8.95%

+364.96K

+1.15%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

18.57M

5.18%

+488.70K

+2.70%

Dec 31, 2024

State Street Global Advisors (US)

15.31M

4.27%

+255.30K

+1.70%

Dec 31, 2024

T. Rowe Price Associates, Inc.

13.96M

3.9%

-133.51K

-0.95%

Dec 31, 2024

Fidelity Management & Research Company LLC

10.49M

2.93%

-117.40K

-1.11%

Dec 31, 2024

Geode Capital Management, L.L.C.

7.76M

2.17%

+243.80K

+3.25%

Dec 31, 2024

Capital World Investors

7.43M

2.07%

+11.93K

+0.16%

Dec 31, 2024

Invesco Capital Management (QQQ Trust)

7.37M

2.06%

+98.84K

+1.36%

Feb 28, 2025

JP Morgan Asset Management

7.22M

2.01%

+123.15K

+1.74%

Dec 31, 2024

Fisher Investments

4.87M

1.36%

+86.49K

+1.81%

Dec 31, 2024

ETF relacionados

Hora de actualización: mar., 1 de abr

Nombre

Proporción

Langar Global HealthTech ETF

19.52%

iShares U.S. Medical Devices ETF

16.03%

Global X Robotics & Artificial Intelligence ETF

11.55%

First Trust Nasdaq Lux Digi Health Solutions ETF

8.42%

Invesco AI and Next Gen Software ETF

7.04%

Franklin Intelligent Machines ETF

6.73%

Goldman Sachs Future Health Care Equity ETF

6.3%

Neuberger Berman Disrupters ETF

6.01%

Inspire 100 ETF

5.52%

iShares Health Innovation Active ETF

5.34%

Langar Global HealthTech ETF

Proporción19.52%

iShares U.S. Medical Devices ETF

Proporción16.03%

Global X Robotics & Artificial Intelligence ETF

Proporción11.55%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporción8.42%

Invesco AI and Next Gen Software ETF

Proporción7.04%

Franklin Intelligent Machines ETF

Proporción6.73%

Goldman Sachs Future Health Care Equity ETF

Proporción6.3%

Neuberger Berman Disrupters ETF

Proporción6.01%

Inspire 100 ETF

Proporción5.52%

iShares Health Innovation Active ETF

Proporción5.34%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

No datos encontrados

División de acciones

Fecha

Tipo

Relación

Aug 05, 2021

Split

1>3

Fecha

Tipo

Relación

Aug 05, 2021

Split

1>3

Intuitive Surgical Inc

451.580USD

Intuitive Surgical Inc

451.580

Descripción general

Compañía